Heart Disease

Adaptable 

This is a trial to assess the best dose of aspirin to use in patients with stable coronary artery disease. Potential participants must receive care at UF Health, Orlando Health or Florida Hospital in Orlando. This is a three-year trial. Please contact 352.273.8933 or email ufcardiovascularct@medicine.ufl.edu for more information.


WARRIOR

Women’s IschemiA TReatment Reduces Events In Non-ObstRuctive CAD

WARRIOR is a four-year, multicenter clinical trial to determine whether aggressive treatment of nonobstructive coronary artery disease (CAD) with medication and lifestyle modification will reduce the likelihood of major adverse events such as stroke, heart attack, heart failure, hospitalization, and death.

WARRIOR Web site for more information about non-obstructive CAD and the trial

info@warriorwomenstrial.com

WARRIOR on clinicaltrials.gov


HARP

This is an observational trial for women presenting to the hospital for a heart attack and do not have obstructive coronary artery disease after undergoing cardiac catheterization. This trial is using various cardiac imaging techniques to improve understanding about plaque and coronary artery disease in women. This trial will last 3 years. Please contact 352.273.8933 or email ufcardiovascularct@medicine.ufl.edu for more information.